MYGN FY 2010 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$473M

FY 2010 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$402M+10.9% YoY

Gross Profit

$355M88.4% margin

Operating Income

$158M39.2% margin

Net Income

$101M25.0% margin

EPS (Diluted)

$1.10

Cash Flow

Operating Cash Flow

$131M

Free Cash Flow

$125M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$611M

Total Liabilities

$44M

Stockholders' Equity

$567M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$402M	$363M	+10.9%
Gross Profit	$355M	$318M	+11.6%
Operating Income	$158M	$135M	+16.8%
Net Income	$101M	$152M	-33.9%